Literature DB >> 22108530

Induced expression of B7-H4 on the surface of lung cancer cell by the tumor-associated macrophages: a potential mechanism of immune escape.

Cheng Chen1, Qiu-Xia Qu, Yu Shen, Chuan-Yong Mu, Yi-Bei Zhu, Xue-Guang Zhang, Jian-An Huang.   

Abstract

B7-homolog 4 (B7-H4), a recently identified homolog of B7.1/2 (CD80/86), has been described to exert co-stimulatory and immune regulatory functions. We investigated the expression and the functional activity of B7-H4 in lung cancer in vitro and in vivo. Although a lung cancer cell line constitutively expressed B7-H4 mRNA and protein in plasma, primary tumor cell isolated from the transplanted lung carcinoma model expressed B7-H4 on the surface. Interestingly, in transplanted lung carcinoma model, the expression of membrane-bound B7-H4 in tumor cells was increased as prolonging of tumor transformation. Exposure to tumor-associated macrophages strongly induced membrane-bound B7-H4 expression on the lung cancer cell line. To elucidate the functional significance of lung cancer-related B7-H4 expression, we performed co-culture experiments of lung cancer cell with allo-reactive T cells. Lung cancer-related B7-H4 was identified as a strong inhibitor of T-cell effect. Furthermore, B7-H4 mAb had an ability to inhibit tumor growth in vivo. B7-H4 expression may thus significantly influence the outcome of T-cell tumor cell interactions and TAM induced membrane-bound B7-H4 on the lung cancer cell represents a novel mechanism by which lung cancer cells evade immune recognition and destruction.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22108530     DOI: 10.1016/j.canlet.2011.11.017

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  30 in total

Review 1.  B7-H4 as a potential target for immunotherapy for gynecologic cancers: a closer look.

Authors:  Jenessa B Smith; Caitlin Stashwick; Daniel J Powell
Journal:  Gynecol Oncol       Date:  2014-03-20       Impact factor: 5.482

Review 2.  Pro-tumorigenic functions of macrophages at the primary, invasive and metastatic tumor site.

Authors:  Elaheh Nasrollahzadeh; Sepideh Razi; Mahsa Keshavarz-Fathi; Massimiliano Mazzone; Nima Rezaei
Journal:  Cancer Immunol Immunother       Date:  2020-06-04       Impact factor: 6.968

3.  Donor and host B7-H4 expression negatively regulates acute graft-versus-host disease lethality.

Authors:  Asim Saha; Patricia A Taylor; Christopher J Lees; Angela Panoskaltsis-Mortari; Mark J Osborn; Colby J Feser; Govindarajan Thangavelu; Wolfgang Melchinger; Yosef Refaeli; Geoffrey R Hill; David H Munn; William J Murphy; Jonathan S Serody; Ivan Maillard; Katharina Kreymborg; Marcel van den Brink; Chen Dong; Shuyu Huang; Xingxing Zang; James P Allison; Robert Zeiser; Bruce R Blazar
Journal:  JCI Insight       Date:  2019-10-03

4.  The Immune Regulator VTCN1 Gene Polymorphisms and Its Impact on Susceptibility to Breast Cancer.

Authors:  Shih-Meng Tsai; Szu-Hsien Wu; Ming-Feng Hou; Hlio-Han Yang; Li-Yu Tsai
Journal:  J Clin Lab Anal       Date:  2014-11-10       Impact factor: 2.352

Review 5.  Potential targeting of B7-H4 for the treatment of cancer.

Authors:  Joseph R Podojil; Stephen D Miller
Journal:  Immunol Rev       Date:  2017-03       Impact factor: 12.988

6.  Dynamic interplay between tumour, stroma and immune system can drive or prevent tumour progression.

Authors:  R J Seager; Cynthia Hajal; Fabian Spill; Roger D Kamm; Muhammad H Zaman
Journal:  Converg Sci Phys Oncol       Date:  2017-07-28

7.  Loss of Peripheral Protection in Pancreatic Islets by Proteolysis-Driven Impairment of VTCN1 (B7-H4) Presentation Is Associated with the Development of Autoimmune Diabetes.

Authors:  Ilian A Radichev; Lilia V Maneva-Radicheva; Christina Amatya; Maryam Salehi; Camille Parker; Jacob Ellefson; Paul Burn; Alexei Y Savinov
Journal:  J Immunol       Date:  2016-01-15       Impact factor: 5.422

8.  Expression of immune checkpoint molecules in endometrial carcinoma.

Authors:  Jia Liu; Yuling Liu; Wuliang Wang; Chenyang Wang; Yanhong Che
Journal:  Exp Ther Med       Date:  2015-08-28       Impact factor: 2.447

9.  Novel recombinant human b7-h4 antibodies overcome tumoral immune escape to potentiate T-cell antitumor responses.

Authors:  Denarda Dangaj; Evripidis Lanitis; Aizhi Zhao; Shree Joshi; Yi Cheng; Raphael Sandaltzopoulos; Hyun-Jeong Ra; Gwenn Danet-Desnoyers; Daniel J Powell; Nathalie Scholler
Journal:  Cancer Res       Date:  2013-05-30       Impact factor: 12.701

10.  Blocking the B7-H4 pathway with novel recombinant antibodies enhances T cell-mediated antitumor responses.

Authors:  Denarda Dangaj; Nathalie Scholler
Journal:  Oncoimmunology       Date:  2013-07-31       Impact factor: 8.110

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.